Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06187584 · ClinicalTrials.gov registry record · Phase 4
SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management
A Phase 4 study of Supracondylar Humerus Fracture, sponsored by Children's Mercy Hospital Kansas City.
- Active
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06187584: Active Phase 4 study of Supracondylar Humerus Fracture, sponsored by Children's Mercy Hospital Kansas City.
NCT06187584 is a Phase 4 study of Supracondylar Humerus Fracture that is active but no longer recruiting, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 160 participants, above the 135-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06187584, a Phase 4 study of Supracondylar Humerus Fracture, is active but no longer recruiting, sponsored by Children's Mercy Hospital Kansas City.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injuries.
Primary Outcome
The subject reported pain level using the scale 0-10, with 0 being no pain and 10 being worst pain, will be measured at the time of discharge (i.e., baseline measure) and once daily at the relative same time each day on postoperative days 1-5. Thus, subjects may have up to a total of six pain level measurements. Higher scores mean a worse outcome.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Hydrocodone/acetaminophen
Study Locations (1)
Missouri
- Children's Mercy Hospital & Clinics - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
What the registry record for NCT06187584 still lists
NCT06187584 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 135-participant average among 3 other Supracondylar Humerus Fracture trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Supracondylar Humerus Fracture appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.
NCT06187584 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06187584 about?
NCT06187584 is a clinical study titled "SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management". This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injur...
What is the current status of trial NCT06187584?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2019-04-15. Estimated completion is 2026-12-31.
What conditions does trial NCT06187584 study?
This clinical trial studies the following conditions: Supracondylar Humerus Fracture.
What interventions are being tested in trial NCT06187584?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Hydrocodone/acetaminophen (DRUG).
Who is sponsoring clinical trial NCT06187584?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06187584 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supracondylar Humerus Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI